In addition, FCX ameliorated insulin resistance by activating insulin receptor substrate 1 (IRS-1)/phosphatidylinositol 3-kinase (PI3K)/Akt and AMP-activated protein kinase (AMPK) signaling pathways in the liver and skeletal muscle of diabetic mice [10,11]. This evidence concerns the gene IRS1 and Insulin resistance.